PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Latest Episodes:

Mohammad AZ Al-Ani, MD, FACC, FSCMR - Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center Sep 26, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/XBK865. CME/MOC/NCPD/CPE/AAPA credit will be available until September 18, 2026.

Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported through an educational grant from Bristol Myers Squibb.

Disclosure information is available at the beginning of the video presentation.

Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment Sep 26, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/FVW865. CME/MOC/CC/AAPA credit will be available until September 28, 2026.

Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment

Support
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Disclosure information is available at the beginning of the video presentation.

Jessica Ailani, MD, FAHS, FAAN - From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies Sep 08, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/PXM865. CME/MOC/AAPA credit will be available until August 26, 2026.

From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies

Support
This activity is supported by an educational grant from Pfizer.

Disclosure information is available at the beginning of the video presentation.

Jared R. Brosch, MD - Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer’s Disease: New Data and Clinical Pearls From AAIC 2025 Sep 01, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.

Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer’s Disease: New Data and Clinical Pearls From AAIC 2025

Support
This activity is supported by an educational grant from Lilly.

Disclosure information is available at the beginning of the video presentation.

Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis Sep 01, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/YFD865. CME credit will be available until August 26, 2026.

Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis

Support
This activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.

Disclosure information is available at the beginning of the video presentation.

Margaret H. Collins, MD, AGAF, Nirmala Gonsalves, MD, AGAF, FACG - Beyond the Eosinophil: Mastering the Complexities of EoE Diagnosis Sep 01, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC information, and to apply for credit, please visit us at PeerView.com/SCH865. CME/MOC/CC credit will be available until August 26, 2026.

Beyond the Eosinophil: Mastering the Complexities of EoE Diagnosis

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Rodger C. Haggitt Gastrointestinal Pathology Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Disclosure information is available at the beginning of the video presentation.

Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes Aug 28, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.

All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes

Support
This activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.

Disclosure information is available at the beginning of the video presentation.

Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations Aug 28, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VFP865. CME/NCPD/CPE/AAPA/IPCE credit will be available until August 18, 2026.

Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations

Support
This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Disclosure information is available at the beginning of the video presentation.

Sami L. Khella, MD - Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists Aug 28, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TDM865. CME credit will be available until August 21, 2026.

Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists

Support
This activity is supported by an independent educational grant from AstraZeneca and Ionis Pharmaceuticals.

Disclosure information is available at the beginning of the video presentation.

Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies Aug 27, 2025

Show notes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WMD865. CME credit will be available until August 20, 2026.

At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies

In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an educational grant from Johnson & Johnson.

Disclosure information is available at the beginning of the video presentation.